Navigation Links
Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
Date:4/15/2008

ZFN Modified Cells Show Glioblastoma Killing in the Presence of

Dexamethasone in Mouse Tumor Model

SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the presentation of positive data in a mouse tumor model from its ZFP Therapeutic(TM) program for the treatment of glioblastoma multiforme (GBM), a progressive and usually fatal brain cancer. The data were presented in the New Approaches to Biological Therapy Session at the 2008 Annual Meeting of the American Association for Cancer Research (AACR) by Sangamo's collaborator Michael C.V. Jensen, M.D., Associate Chair, Division of Cancer Immunotherapeutics & Tumor Immunology, City of Hope.

"In collaboration with Sangamo, we have successfully generated engineered T-cells that can destroy glioblastoma tumor cells in animals in the presence of glucocorticoids," said Dr. Jensen. "Treatment of recurrent GBM with modified T-cells, an otherwise promising approach for this cancer, is rendered ineffective by the use of glucocorticoids to control inflammation of the brain due to the tumor and surgery. These data show that we have solved that problem and are making significant progress in our efforts to create an 'off-the-shelf' cell-based product for the treatment of GBM. The ZFN(TM)-modification of the glucocorticoid receptor (GR) in our engineered T-cells protects the cells from the effects of glucocorticoids which would normally inhibit T-cell function, and in addition, does not alter their cytolytic or tumor-killing properties."

Dr. Jensen has developed novel chimeric immunoreceptors called "zetakines" that can be engineered into human immune cells to generate a population of cells that can specifically
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
2. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
3. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
4. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
5. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
6. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
7. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
8. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
9. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
10. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
11. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ov. 20 Reportlinker.com announces ...its catalogue. ,, Blood Pressure Monitoring &a...sis ,, http://www.reportlinker.com/p0164309/...---A-World-Market-Analysis.html#utm_source=prnewsw... ,, Measurement of blood pressure is not only ...
(Date:11/20/2009)...ov. 20 ,, Reportlinker.com anno...le in its catalogue. ,, Global Markets for Bre...linker.com/p0164741/Global-Markets-for-Breast-Biop..._medium=pr&utm_campaign=prnewswire ,, The... the spring loaded core needle market and vacuum a...
(Date:11/20/2009)... 20 Biotel Inc. (OTC Bul... quarter ended September 30, 2009 with net earning...nues of $3,263,000. This compares to net earnings...ues of $3,168,000 for the first quarter of last ye... Biotel President and CEO Steve Springrose said: "...
Breaking Medicine Technology:Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 4Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 5Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 6Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 7Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 8Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 9Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Biotel Announced Profitable First Quarter Ended September 30, 2009 2Revenue Management Solutions LLC Receives EHNAC Financial Services Accreditation 54265 1Revenue Management Solutions LLC Receives EHNAC Financial Services Accreditation 54265 2Revenue Management Solutions LLC Receives EHNAC Financial Services Accreditation 54265 3Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 1Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 2Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 3Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 4Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 5Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 6Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 7Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 8WuXi PharmaTech Announces Second Quarter 2009 Results 13509 1WuXi PharmaTech Announces Second Quarter 2009 Results 13509 2WuXi PharmaTech Announces Second Quarter 2009 Results 13509 3WuXi PharmaTech Announces Second Quarter 2009 Results 13509 4WuXi PharmaTech Announces Second Quarter 2009 Results 13509 5WuXi PharmaTech Announces Second Quarter 2009 Results 13509 6WuXi PharmaTech Announces Second Quarter 2009 Results 13509 7WuXi PharmaTech Announces Second Quarter 2009 Results 13509 8WuXi PharmaTech Announces Second Quarter 2009 Results 13509 9WuXi PharmaTech Announces Second Quarter 2009 Results 13509 10WuXi PharmaTech Announces Second Quarter 2009 Results 13509 11WuXi PharmaTech Announces Second Quarter 2009 Results 13509 12WuXi PharmaTech Announces Second Quarter 2009 Results 13509 13WuXi PharmaTech Announces Second Quarter 2009 Results 13509 14WuXi PharmaTech Announces Second Quarter 2009 Results 13509 15WuXi PharmaTech Announces Second Quarter 2009 Results 13509 16
...8 The Association,for Professionals in Infection ...at Rachel L. Stricof, MT, MPH, of Albany, NY, has ...arole DeMille Achievement Award.,APIC presents the...ol,professional who best exemplifies the ideals of...he award will be presented at the APIC 35th Annual...
...ena,Pharmaceuticals, Inc. (Nasdaq: ARNA ) announc... clinical trial of APD125 in patients with primary...ered by Arena with the,potential to reduce insomni...ty., The Phase 2b trial of APD125 is a double-bli...dy evaluating the efficacy and tolerability of,APD...
Other Medicine Technology:New York Infection Prevention Expert Named Recipient of Carole DeMille Award 2Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 3Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 4Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 5
(Date:11/20/2009)..., Pioneering Neurologist Closer to Understanding B... Dr. Jeremy Schmahmann,...and neurologist at the Massachusetts General Hospi... his laboratory,s research on the new field of stu...link Foundation. ,, Dr. Schmahmann is an award-...
(Date:11/20/2009)..., QUINCY, Mass., Nov. 20 Following...ket Company removed from sale Shedd,s Country Croc...and Shedd,s Country Crock ® Side Dishes DELUX...llergen. ,, The following code dates and UPCs ...Side Dishes DELUXE Cheddar Broccoli Rice 21 oz, UP...
(Date:11/20/2009)..., ST. LOUIS, Nov. 20 ...ed that it will present at the Bank of America Mer...mber 2-3, 2009, at the Crowne Plaza Hotel Times Sq...Wednesday, December 2nd at 8:30 a.m. Eastern Time.... a live, audio webcast of Centene,s presentation a...
(Date:11/20/2009)... , NEW YORK, Nov. 20 ...d that it will broadcast Doctor Radio Reports: ...an in-depth special hosted by veteran journalist P...cgi-bin/prnh/20080819/NYTU044LOGO ) ,, Doctor ...out Mammograms will air November 21 live at 10:...
(Date:11/20/2009)...e, Washington) November 20, 2009Emergency medical ...s an estimated 350,000 cardiac arrests each year. ...rdiac arrest survive. Better quality cardiopulmon...S providers may be associated with better patient ...OC) is the largest clinical research network to st...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...hua-PRNewswire-FirstCall/ -- Shengtai,Pharmaceutic...rmaceutical",or "the Company"), a leading manufact...l grade glucose products in China, today announced...ny,s presentation at the,conference are as follows...
... employers and others can use the science of behav...es and dramatically improve their health without...rding to an article published in the Nov. 28 issue...sylvania, Aetna Inc. and the Philadelphia Veterans...
...archTechnology,Inc. (eRT), (Nasdaq: ERES ), a lea...armaceutical, biotechnology and medical device ind...ire the centralized ECG business,of Covance Inc. I...,s clients. It is expected that the acquisition wi...
... In its continued,educational and research effort...tories disputes an editorial comment published in ... its author has misinterpreted results of,clinical... In his commentary, Goldacre,suggests that the res...
...r Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH) today ann...rman of the Board and a member of the Board of Dir...ears of service with the Company. John L.,McGoldri...ny from August 2001 to May 2007 when David C. Dvor...
... Rate..., CLEARWATER, Fla., Nov. 27 minSURG Corp...Development Corporation, announced,today that it h...e fusion,technique., Over 400 spine surgeons were... reasonable predictor that TruFUSE,has the potenti...
Other Medicine News:Health News:Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference 2Health News:Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference 3Health News:Doctors, economist, write prescription for protecting people from themselves 2Health News:Doctors, economist, write prescription for protecting people from themselves 3Health News:eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance 2Health News:Boiron Laboratories Disputes British Journal's Editorial on Homeopathy 2Health News:Boiron Laboratories Disputes British Journal's Editorial on Homeopathy 3Health News:Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman 2Health News:Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman 3Health News:Over 600 Surgeons Certified to use TruFUSE(R) to Treat Back Pain Sufferers 2
Trans-Blot Cell with Plate Electrodes
Criterion Gel/Wire Blot System
Criterion Gel/Plate Blot System
...to easily transfer proteins or nucleic acids from ...ell SureLock and XCell II Mini-Cells in place of t... 200 ml of transfer buffer for western Southern an...d stainless steel electrodes create a uniform elec...
Medicine Products: